The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Abuse Treatment Market Research Report 2024
Synopsis
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
The global Drug Abuse Treatment market was valued at US$ 18170 million in 2023 and is anticipated to reach US$ 28570 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.
This report aims to provide a comprehensive presentation of the global market for Drug Abuse Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Abuse Treatment.
Report Scope
The Drug Abuse Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Abuse Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Abuse Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segment by Application
Hospital & Clinics
Residential (non-hospital)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Abuse Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
The global Drug Abuse Treatment market was valued at US$ 18170 million in 2023 and is anticipated to reach US$ 28570 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.
This report aims to provide a comprehensive presentation of the global market for Drug Abuse Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Abuse Treatment.
Report Scope
The Drug Abuse Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Abuse Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Abuse Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segment by Application
Hospital & Clinics
Residential (non-hospital)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Abuse Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Abuse Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Opioid Addiction
1.2.3 Tobacco/Nicotine Addiction
1.2.4 Alcohol Dependence
1.3 Market by Application
1.3.1 Global Drug Abuse Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital & Clinics
1.3.3 Residential (non-hospital)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Abuse Treatment Market Perspective (2019-2030)
2.2 Drug Abuse Treatment Growth Trends by Region
2.2.1 Global Drug Abuse Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Abuse Treatment Historic Market Size by Region (2019-2024)
2.2.3 Drug Abuse Treatment Forecasted Market Size by Region (2025-2030)
2.3 Drug Abuse Treatment Market Dynamics
2.3.1 Drug Abuse Treatment Industry Trends
2.3.2 Drug Abuse Treatment Market Drivers
2.3.3 Drug Abuse Treatment Market Challenges
2.3.4 Drug Abuse Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Abuse Treatment Players by Revenue
3.1.1 Global Top Drug Abuse Treatment Players by Revenue (2019-2024)
3.1.2 Global Drug Abuse Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Drug Abuse Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Abuse Treatment Revenue
3.4 Global Drug Abuse Treatment Market Concentration Ratio
3.4.1 Global Drug Abuse Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Abuse Treatment Revenue in 2023
3.5 Drug Abuse Treatment Key Players Head office and Area Served
3.6 Key Players Drug Abuse Treatment Product Solution and Service
3.7 Date of Enter into Drug Abuse Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Abuse Treatment Breakdown Data by Type
4.1 Global Drug Abuse Treatment Historic Market Size by Type (2019-2024)
4.2 Global Drug Abuse Treatment Forecasted Market Size by Type (2025-2030)
5 Drug Abuse Treatment Breakdown Data by Application
5.1 Global Drug Abuse Treatment Historic Market Size by Application (2019-2024)
5.2 Global Drug Abuse Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Abuse Treatment Market Size (2019-2030)
6.2 North America Drug Abuse Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Abuse Treatment Market Size by Country (2019-2024)
6.4 North America Drug Abuse Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Abuse Treatment Market Size (2019-2030)
7.2 Europe Drug Abuse Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Abuse Treatment Market Size by Country (2019-2024)
7.4 Europe Drug Abuse Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Abuse Treatment Market Size (2019-2030)
8.2 Asia-Pacific Drug Abuse Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Abuse Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Abuse Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Abuse Treatment Market Size (2019-2030)
9.2 Latin America Drug Abuse Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Abuse Treatment Market Size by Country (2019-2024)
9.4 Latin America Drug Abuse Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Abuse Treatment Market Size (2019-2030)
10.2 Middle East & Africa Drug Abuse Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Abuse Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Abuse Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Indivior
11.1.1 Indivior Company Detail
11.1.2 Indivior Business Overview
11.1.3 Indivior Drug Abuse Treatment Introduction
11.1.4 Indivior Revenue in Drug Abuse Treatment Business (2019-2024)
11.1.5 Indivior Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drug Abuse Treatment Introduction
11.2.4 Pfizer Revenue in Drug Abuse Treatment Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Alkermes
11.3.1 Alkermes Company Detail
11.3.2 Alkermes Business Overview
11.3.3 Alkermes Drug Abuse Treatment Introduction
11.3.4 Alkermes Revenue in Drug Abuse Treatment Business (2019-2024)
11.3.5 Alkermes Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Drug Abuse Treatment Introduction
11.4.4 Novartis Revenue in Drug Abuse Treatment Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Detail
11.5.2 Mylan Business Overview
11.5.3 Mylan Drug Abuse Treatment Introduction
11.5.4 Mylan Revenue in Drug Abuse Treatment Business (2019-2024)
11.5.5 Mylan Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Drug Abuse Treatment Introduction
11.6.4 Cipla Revenue in Drug Abuse Treatment Business (2019-2024)
11.6.5 Cipla Recent Development
11.7 Glenmark
11.7.1 Glenmark Company Detail
11.7.2 Glenmark Business Overview
11.7.3 Glenmark Drug Abuse Treatment Introduction
11.7.4 Glenmark Revenue in Drug Abuse Treatment Business (2019-2024)
11.7.5 Glenmark Recent Development
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Detail
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Drug Abuse Treatment Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drug Abuse Treatment Business (2019-2024)
11.8.5 Dr. Reddy's Laboratories Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Detail
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Drug Abuse Treatment Introduction
11.9.4 Teva Pharmaceutical Revenue in Drug Abuse Treatment Business (2019-2024)
11.9.5 Teva Pharmaceutical Recent Development
11.10 PLIVA (Odyssey)
11.10.1 PLIVA (Odyssey) Company Detail
11.10.2 PLIVA (Odyssey) Business Overview
11.10.3 PLIVA (Odyssey) Drug Abuse Treatment Introduction
11.10.4 PLIVA (Odyssey) Revenue in Drug Abuse Treatment Business (2019-2024)
11.10.5 PLIVA (Odyssey) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
